Literature DB >> 2908897

Morphologic alterations in rat brain following systemic and intraventricular methotrexate injection: light and electron microscopic studies.

J B Gregorios1, A B Gregorios, J Mora, A Marcillo, R M Fojaco, B Green.   

Abstract

To determine the morphological substrate of acute methotrexate (MTX) encephalopathy, light and electron microscopic studies were performed on rat brains after short-term intraperitoneal (IP) and intraventricular (IV) injections of MTX. In both models, Alzheimer type II astrocytosis was the initial and major pathologic alteration seen by light microscopy. The neurons, oligodendrocytes, myelin and endothelial cells were relatively spared. Ultrastructural studies showed pleomorphism and condensation of mitochondria, membrane-bound vacuoles, prominent stacks of sparsely granular, rough endoplasmic reticulum and progressive hydropic swelling of astrocytic perikarya and their processes. The astroglial alterations were reversible after cessation of the drug but persisted for a longer time with repeated IP administration. Gastrointestinal complications and overall mortality were also greater with higher doses and increasing frequency of IP MTX injection. White matter necrosis was noted only after IV injection of high-dose MTX. The neuropathologic changes of MTX leukoencephalopathy can be replicated in an animal model by IV injection of the drug. The reversibility of the changes that were seen following IP administration correlates with the transient neurologic deficits observed in some patients after high-dose systemic MTX therapy. The initially selective astroglial effect suggests that astrocytes might be a target for MTX toxicity, although other central nervous system components may also be adversely affected by the drug.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2908897     DOI: 10.1097/00005072-198901000-00004

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  8 in total

1.  Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy.

Authors:  Vincent Koppelmans; Marius de Groot; Michiel B de Ruiter; Willem Boogerd; Caroline Seynaeve; Meike W Vernooij; Wiro J Niessen; Sanne B Schagen; Monique M B Breteler
Journal:  Hum Brain Mapp       Date:  2012-12-20       Impact factor: 5.038

Review 2.  TNF-alpha and neuropathic pain--a review.

Authors:  Lawrence Leung; Catherine M Cahill
Journal:  J Neuroinflammation       Date:  2010-04-16       Impact factor: 8.322

3.  Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors.

Authors:  Emily B Bisen-Hersh; Philip N Hineline; Ellen A Walker
Journal:  Clin Cancer Res       Date:  2013-04-17       Impact factor: 12.531

4.  High-dose methotrexate does not affect the pharmacodynamics of phenobarbital hypnotic action but decreases the central nervous system (CNS) sensitivity to pentylenetetrazol-induced maximal seizures in rats.

Authors:  A Hoffman; J Alfon
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

5.  Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Irina Chadaeva; Dmitry A Rasskazov; Ekaterina Sharypova; Elena V Kashina; Irina Drachkova; Dmitry Zhechev; Mikhail P Ponomarenko; Ludmila K Savinkova; Nikolay Kolchanov
Journal:  Front Aging Neurosci       Date:  2017-07-20       Impact factor: 5.750

Review 6.  Chemotherapy and the pediatric brain.

Authors:  Chrysanthy Ikonomidou
Journal:  Mol Cell Pediatr       Date:  2018-11-06

7.  The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series.

Authors:  Andrea Santangelo; Emanuele Bartolini; Giulia Nuzzi; Thomas Foiadelli; Alexandre Michev; Tommaso Mina; Irene Trambusti; Valeria Fichera; Alice Bonuccelli; Gabriele Massimetti; Diego G Peroni; Emanuela De Marco; Luca Coccoli; Laura Luti; Sayla Bernasconi; Margherita Nardi; Maria Cristina Menconi; Gabriella Casazza; Dario Pruna; Rosamaria Mura; Chiara Marra; Daniele Zama; Pasquale Striano; Duccio M Cordelli; Roberta Battini; Alessandro Orsini
Journal:  Front Neurol       Date:  2022-06-10       Impact factor: 4.086

8.  Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice.

Authors:  Andre M Mueller; Adam Nassery; Hana Conlon; Xinhe Liu; Esther Jun; Bo Hyung Yoon; Massimiliano Cristofanilli; Saud A Sadiq
Journal:  Front Mol Neurosci       Date:  2013-10-16       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.